Following the Concentration of Polymeric Nanoparticles During Nebulization

被引:37
作者
Beck-Broichsitter, Moritz [1 ]
Knuedeler, Marie-Christine [1 ]
Schmehl, Thomas [1 ]
Seeger, Werner [1 ]
机构
[1] Univ Giessen, Dept Internal Med, Med Clin 2, D-35392 Giessen, Germany
关键词
aggregation; biodegradable nanoparticles; concentration changes; pulmonary drug delivery; vibrating-membrane nebulization; BIODEGRADABLE NANOPARTICLES; DRUG-DELIVERY; NANOTECHNOLOGY; PERFORMANCE; FORMULATION; DESIGN; IMPACT; NANO; JET;
D O I
10.1007/s11095-012-0819-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Nebulization represents one strategy to achieve pulmonary deposition of biodegradable nanoparticles. Besides stability as a key requirement to maintain functionality, the output of nanoparticles from the nebulizer needs to be considered to facilitate an efficient pulmonary therapy. Formulations nebulized by air-jet and vibrating-membrane technology were analyzed for their aerodynamic characteristics by laser diffraction. The nebulization stability of poly(D,L-lactide-co-glycolide) nanoparticles was assessed by dynamic light scattering. Moreover, several methods were employed to account for the shift in solute and NP reservoir concentration during nebulization. Regardless of the formulation or nebulizer used generated aerosols all showed aerodynamic characteristics suitable for deep lung deposition. However, nanoparticles were prone to aggregation and concentrated during air-jet nebulization. The particle concentration effect was significantly pronounced in comparison to molecular solutes under the same nebulization conditions, due to nanoparticle aggregation and subsequent particle remainder in the reservoir. In contrast, vibrating-membrane technology did not affect nanoparticle integrity and reservoir concentration during nebulization, as the unaffected submicron particles passed through the tapered holes of the actuated plate. Aggregation and concentration effects during air-jet nebulization emphasize that nanosuspensions should preferably be delivered with a suitable vibrating-membrane device in order to ensure an effective pulmonary application.
引用
收藏
页码:16 / 24
页数:9
相关论文
共 36 条
[21]  
Lass Joseph S, 2006, Expert Opin Drug Deliv, V3, P693, DOI 10.1517/17425247.3.5.693
[22]   Moving smaller in drug discovery and delivery [J].
LaVan, DA ;
Lynn, DM ;
Langer, R .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :77-84
[23]   Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation [J].
Lebhardt, Tobias ;
Roesler, Susanne ;
Uusitalo, Henna P. ;
Kissel, Thomas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 78 (01) :90-96
[24]   Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers [J].
McCallion, ONM ;
Taylor, KMG ;
Thomas, M ;
Taylor, AJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 133 (1-2) :203-214
[25]   Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers [J].
Mitchell, Jolyon P. ;
Nagel, Mark W. ;
Nichols, Steve ;
Nerbrink, Ola .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2006, 19 (04) :409-433
[26]   Pulmonary Gene Silencing in Transgenic EGFP Mice Using Aerosolised Chitosan/siRNA Nanoparticles [J].
Nielsen, Ebbe J. B. ;
Nielsen, Jan M. ;
Becker, Daniel ;
Karlas, Alexander ;
Prakash, Hridayesh ;
Glud, Sys Z. ;
Merrison, Jonathan ;
Besenbacher, Flemming ;
Meyer, Thomas F. ;
Kjems, Jorgen ;
Howard, Kenneth A. .
PHARMACEUTICAL RESEARCH, 2010, 27 (12) :2520-2527
[27]   Inhaled iloprost for severe pulmonary hypertension [J].
Olschewski, H ;
Simonneau, G ;
Galiè, N ;
Higenbottam, T ;
Naeije, R ;
Rubin, LJ ;
Nikkho, S ;
Speich, R ;
Hoeper, MM ;
Behr, J ;
Winkler, J ;
Sitbon, O ;
Popov, W ;
Ghofrani, HA ;
Manes, A ;
Kiely, DG ;
Ewert, R ;
Siedentop, H ;
Seeger, W .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05) :322-329
[28]   Stabilization of Aerosolizable Nano-carriers by Freeze-Drying [J].
Packhaeuser, Claudia B. ;
Lahnstein, Kerstin ;
Sitterberg, Johannes ;
Schmehl, Thomas ;
Gessler, Tobias ;
Bakowsky, Udo ;
Seeger, Werner ;
Kissel, Thomas .
PHARMACEUTICAL RESEARCH, 2009, 26 (01) :129-138
[29]   Inhaling medicines: delivering drugs to the body through the lungs [J].
Patton, John S. ;
Byron, Peter R. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (01) :67-74
[30]   In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles [J].
Rytting, Erik ;
Bur, Michael ;
Cartier, Regis ;
Bouyssou, Thierry ;
Wang, Xiaoying ;
Krueger, Michael ;
Lehr, Claus-Michael ;
Kissel, Thomas .
JOURNAL OF CONTROLLED RELEASE, 2010, 141 (01) :101-107